ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Founded in 2020, ROME Therapeutics is backed by investors that include ARCH Venture Partners, GV, and Partners Innovation Fund and is headquartered in Cambridge.